Global Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape 2021-2027 - ResearchAndMarkets.com

DUBLIN--()--The "Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global human microbiome therapeutics market is expected to grow at a CAGR of around 42.7% during 2021-2027.

This report on global human microbiome therapeutics market report provides a holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global human microbiome therapeutics market by segmenting the market based on technology, therapeutic area, type, and region.

Also, detailed profiles of companies operating in the human microbiome therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making an informed decision.

Market Drivers

  • Human Microbiome as a Validated Target for Drug Development
  • Increasing Focus on Human Microbiome Therapeutics Development
  • Increasing Collaboration Between Public-Private Organizations

Market Challenges

  • Stringent Government Regulations
  • Lack of Expertise and Adequate Research

Historical & Forecast Period

Base Year: 2020

Historical Period: 2016-2019

Forecast Period: 2021-2027

Market by Technology

  • Genomics
  • Proteomics
  • Metabolomics

Market by Route of Therapeutic Area

  • Neurological Disorders
  • Dermatological Indications
  • Cancers
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Others

Market by Type

  • Probiotics and Prebiotics
  • Medical Food
  • Diagnostic Tests
  • Others

Market by Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Companies Mentioned

  • Bristol-Myers Squibb
  • Dow Inc Chemical
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson
  • DuPont de Nemours, Inc.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Vertex Pharmaceuticals
  • Evelo Biosciences, Inc.
  • Kaleido Biosciences, Inc.
  • Seres Therapeutics, Inc.
  • PureTech Health PLC

For more information about this report visit https://www.researchandmarkets.com/r/9ca6ic

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900